PA
CEPF

PharVision Advisers’s Cantor Equity Partners IV CEPF Stock Holding History

PharVision Advisers’s Portfolio CEPF Stock Details CEPF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,892
Closed -$143K – 702
2025
Q4 		$143K Buy
+13,892
New +$144K 0.07% 619

Other funds holding CEPF

HCI
Harraden Circle Investments New York $784M AUM 20.59% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return

PharVision Advisers's CEPF Position: Q1 2026 in Review

PharVision Advisers sold out of Cantor Equity Partners IV (CEPF) in Q1 2026, closing a stake of 13,892 shares — an estimated $143K sold.

PharVision Advisers first reported a position in CEPF in Q4 2025 and held it in 1 quarter. The position peaked at $143K in Q4 2025. 93 funds tracked by Wall St. Rank hold CEPF as of Q1 2026.

  • PharVision Advisers reported no remaining Cantor Equity Partners IV position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 13,892 Cantor Equity Partners IV shares in Q1 2026, an estimated $143K.
  • PharVision Advisers first reported a position in Cantor Equity Partners IV in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's Cantor Equity Partners IV position peaked at $143K in Q4 2025.
  • 93 funds tracked by Wall St. Rank held Cantor Equity Partners IV as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.